European Society for Medical Oncology Preceptorship on Colorectal Cancer Valencia 2023
Format: 23 videos + 24 pdfs, size: 2.49 GB
Course Audience: oncologist
Overview:
- Start date 19 May 2023
- End date 20 May 2023
- Location Valencia, Spain
Learning objectives
- To learn about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and metastatic settings
- To understand the importance of pathology, histo- and moleculopathological prognostic factors
- To learn about sequencing of treatments, adverse events and special situations
ESMO-Preceptorship-on-Colorectal-Cancer-2023-Valencia-Programme (PDF Format)
Session 1 Adjuvant Treatment for Colon Cancer Stage II and III as Standard of Care (Video MP4 Format)Session 1 Adjuvant Treatment for Colon Cancer Stage II and III as Standard of Care (PDF Format)Session 1 Neoadjuvant Chemotherapy for Localised Colon Cancer as a Potential Option (Video MP4 Format)Session 1 Neoadjuvant Chemotherapy for Localised Colon Cancer as a Potential Option (PDF Format)Session 1 Quality and Rules of a Good Pathology Report – Histo- and Moleculopathological Biomarkers (Video MP4 Format)Session 1 Quality and Rules of a Good Pathology Report – Histo- and Moleculopathological Biomarkers (PDF Format)Session 2 Neoadjuvant Immunotherapy for Localised Colorectal Cancer Facts and Future Prospective (Video MP4 Format)Session 2 Neoadjuvant Immunotherapy for Localised Colorectal Cancer Facts and Future Prospective (PDF Format)Session 2 Participants Clinical Case Discussion on Localised Colon Cancer – ctDNA Monitoring in Localized Colon Cancer Evidences (Video MP4 Format)Session 2 Participants Clinical Case Discussion on Localised Colon Cancer – ctDNA Monitoring in Localized Colon Cancer Evidences (PDF Format)Session 2 Participants Clinical Case Discussion on Localised Colon Cancer – Managing Locally Advanced dMMR Colon Cancer with Neoadjuvant Immunotherapy (Video MP4 Format)Session 2 Participants Clinical Case Discussion on Localised Colon Cancer – Managing Locally Advanced dMMR Colon Cancer with Neoadjuvant Immunotherapy (PDF Format)Session 2 Participants Clinical Case Discussion on Localised Colon Cancer – Total Neoadjuvant Therapy for Rectal Cancer (Video MP4 Format)Session 2 Participants Clinical Case Discussion on Localised Colon Cancer – Total Neoadjuvant Therapy for Rectal Cancer (PDF Format)Session 3 Current Treatment of Metastatic Colorectal Cancer Basic Strategies According to Clinical and Molecular Subgroups MSI-H (Video MP4 Format)Session 3 Current Treatment of Metastatic Colorectal Cancer Basic Strategies According to Clinical and Molecular Subgroups MSI-H (PDF Format)Session 3 Presentation of Three Challenging Clinical Cases by the Expert and Faculty Discussion (Video MP4 Format)Session 3 Presentation of Three Challenging Clinical Cases by the Expert and Faculty Discussion (PDF Format)Session 4 How to Integrate Surgery in the Treatment of Patients with Liver-only Metastatic Disease (Video MP4 Format)Session 4 How to Integrate Surgery in the Treatment of Patients with Liver-only Metastatic Disease (PDF Format)Session 4 Oligometastatic Colorectal Cancer What to Know about it and How to Treat it (Video MP4 Format)Session 4 Oligometastatic Colorectal Cancer What to Know about it and How to Treat it (PDF Format)Session 4 Participants Clinical Case Discussion – A DPYD Variant with mCRC and Inoperable Liver Metastasis (Video MP4 Format)Session 4 Participants Clinical Case Discussion – A DPYD Variant with mCRC and Inoperable Liver Metastasis (PDF Format)Session 4 Participants Clinical Case Discussion – Maintenance Treatment with Cetuximab in RAS Wild-type Metastatic Colorectal Cancer (Video MP4 Format)Session 4 Participants Clinical Case Discussion – Maintenance Treatment with Cetuximab in RAS Wild-type Metastatic Colorectal Cancer (PDF Format)Session 4 Participants Clinical Case Discussion – Surgery and Triplet Chemotherapy with Liver-only Metastatic Disease (Video MP4 Format)Session 4 Participants Clinical Case Discussion – Surgery and Triplet Chemotherapy with Liver-only Metastatic Disease (PDF Format)Session 5 How to Deal with Patients with BRAF Mutant and HER2 Amplified Advanced Colorectal Cancer after 1st Failure (Video MP4 Format)Session 5 How to Deal with Patients with BRAF Mutant and HER2 Amplified Advanced Colorectal Cancer after 1st Failure (PDF Format)Session 5 Management of Treatment-related Side Effects (Video MP4 Format)Session 5 Management of Treatment-related Side Effects (PDF Format)Session 5 Treating Patients with Chemorefractory Disease Challenges and Opportunities (Video MP4 Format)Session 5 Treating Patients with Chemorefractory Disease Challenges and Opportunities (PDF Format)Session 5 What to Do after First-line Failure (Video MP4 Format)Session 5 What to Do after First-line Failure (PDF Format)Session 6 Standard of Care of Localised Rectal Cancer (Video MP4 Format)Session 6 Standard of Care of Localised Rectal Cancer (PDF Format)Session 7 Participants Clinical Case Discussion – Encorafenib Plus Cetuximab after First-line Immunotherapy in dMMR BRAF V600E Metastatic Colorectal Cancer (Video MP4 Format)Session 7 Participants Clinical Case Discussion – Encorafenib Plus Cetuximab after First-line Immunotherapy in dMMR BRAF V600E Metastatic Colorectal Cancer (PDF Format)Session 7 Participants Clinical Case Discussion – Great Response in 2L with a KRAS G12C Inhibitor More Proof that KRAS is Indeed Druggable (Video MP4 Format)Session 7 Participants Clinical Case Discussion – Great Response in 2L with a KRAS G12C Inhibitor More Proof that KRAS is Indeed Druggable (PDF Format)Session 7 Participants Clinical Case Discussion – HER-2 in Colorectal Cancer Success Story (Video MP4 Format)Session 7 Participants Clinical Case Discussion – HER-2 in Colorectal Cancer Success Story (PDF Format)Welcome and Introduction (Video MP4 Format)Welcome and Introduction (PDF Format)